Journal
CELL STEM CELL
Volume 27, Issue 2, Pages 192-194Publisher
CELL PRESS
DOI: 10.1016/j.stem.2020.07.010
Keywords
-
Categories
Funding
- NCI NIH HHS [P50 CA211015] Funding Source: Medline
- NIGMS NIH HHS [T32 GM008042] Funding Source: Medline
Ask authors/readers for more resources
Senescence is a critical factor in several diseases, yet senolytic therapies targeting senescent cells remain hindered by lack of specificity. In the June issue of Nature, Amor et al. (2020) develop chimeric antigen receptor (CAR)-T cells targeting uPAR, a novel senescent-cell marker, to treat liver adenocarcinoma and liver fibrosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
